New NICE guidelines include CLAHRC supported research on early intervention in Psychosis 

Originating under CLAHRC Cambridge and Peterborough, the research looked at the epidemiology and the heterogeneity in the incidence of psychotic disorders. The findings were translated into an online tool called PsyMaptic, and have been included in new guidelines from the National Institute for Health and Care Excellence (NICE). PsyMaptic is a freely available population prediction tool to guide commissioning early intervention services (EIS) in the NHS for people suffering with a first episode of psychotic illnesses.

EIS are clinically and cost-effective and are now subject to access and waiting time standards. The services are being re-commissioned throughout England.

Many key organisations are using the PsyMaptic tool to support the process:

  • Public Health England (PHE) has incorporated the PsyMaptic predictions into its health indicators gazetteer.
  • Health Education England (HEE) is currently using the predictions in their Workforce Planning Guidance.
  • All clinical commissioning groups (CCGs) in England have been using Psymaptic since December 2015 to recommission EIS

There is interest in PsyMaptic from other European countries and the USA, and Public Health England is commissioning a similar mapping approach for prevalent mental illness in order to further enhance Fingertips.

Please see the NICE Guidance for more information 

The PsyMaptic tool was developed by Dr James Kirkbride (currently based in the Division of Psychiatry, University College London), while he was part of the EpiCentre group in the Department of Psychiatry, University of Cambridge. Dr Kirkbride worked with Professor Peter Jones (NIHR CLAHRC EoE Director), with funding from the Wellcome Trust and with support from CLAHRC EoE.



Share this article
Tweet about this on Twitter